ERIE vs AFG vs CNA
161 measures in 16 categories, one definition each, computed from filings and market data.
ERIE64.1
Erie Indemnity Company
Financial Services · Insurance - Property & Casualty
$243.71 +2.10%$11.3B mkt cap
Score DNA
AFG53.3
American Financial Group, Inc.
Financial Services · Insurance - Property & Casualty
$149.13 +2.33%$12.4B mkt cap
Score DNA
CNA54.2
CNA Financial Corporation
Financial Services · Insurance - Property & Casualty
$47.90 +1.31%$13.0B mkt cap
Score DNA
Price, rebased to 100 three years ago
ERIE AFG CNA · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Insider open-market buys, 180d | 3 | 0 | 0 |
| Insider $ bought, 180d | $1.43M | — | — |
| Congress purchases, 180d | 4 | 0 | 0 |
| Last Congress purchase | 2026-03-30 | — | — |
| 13F net change in holders | +40 | +25 | +15 |
| ETFs adding shares, 30d | 413 | 397 | 104 |
| ETFs trimming, 30d | 302 | 315 | 95 |
| Net ETF funds, 30d | +111 | +82 | +9 |
Valuation
16 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| P/E (TTM) | 19.5x
91st
|
13.0x
71st
|
9.6x
33rd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.08
93rd
|
2.78
100th
|
0.49
74th
|
| Price / sales | 2.6x
81st
|
1.5x
60th
|
0.9x
25th
|
| Price / book | 4.6x
92nd
|
2.6x
74th
|
1.2x
20th
|
| Price / tangible book | 5.1x
90th
|
2.8x
67th
|
1.3x
22nd
|
| Price / free cash flow | n/a | n/a | n/a |
| Price / operating cash flow | n/a | n/a | n/a |
| Enterprise value | n/a | n/a | n/a |
| EV / sales | n/a | n/a | n/a |
| EV / EBITDA | n/a | n/a | n/a |
| EV / EBIT | n/a | n/a | n/a |
| EV / free cash flow | n/a | n/a | n/a |
| Earnings yield | 5.1%
21st
|
7.7%
38th
|
10.4%
71st
|
| FCF yield | n/a | n/a | n/a |
| Operating cash flow yield | n/a | n/a | n/a |
| Graham number (per share) | $108.21
60th
|
$122.50
62nd
|
$67.82
44th
|
Profitability (TTM)
12 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Gross margin | n/a | n/a | n/a |
| EBITDA margin | n/a | n/a | n/a |
| Operating margin | 16.9%
63rd
|
14.7%
54th
|
10.9%
33rd
|
| EBIT margin | 16.3%
63rd
|
15.8%
54th
|
11.3%
33rd
|
| Net margin | 13.2%
69th
|
11.6%
56th
|
9.0%
35th
|
| NOPAT margin | 13.3%
62nd
|
11.6%
56th
|
10.5%
42nd
|
| FCF margin | n/a | n/a | n/a |
| Operating cash flow margin | n/a | n/a | n/a |
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 5.8%
52nd
|
0.0%
0th
|
11.4%
65th
|
| Stock comp / revenue | — | — | 0.0%
0th
|
| Effective tax rate | 21.3%
68th
|
20.7%
40th
|
2.9%
4th
|
Returns on capital
11 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| ROE (on average equity) | 24.8%
74th
|
20.4%
56th
|
12.3%
28th
|
| ROA | 17.3%
98th
|
3.0%
38th
|
1.9%
19th
|
| ROIC | n/a | n/a | n/a |
| ROCE | n/a | n/a | n/a |
| Return on tangible assets | 21.3%
98th
|
4.1%
35th
|
2.5%
17th
|
| Cash ROIC (OCF / invested capital) | n/a | n/a | n/a |
| Gross profitability (GP / assets) | n/a | n/a | n/a |
| ROIC, 3-yr average | n/a | n/a | n/a |
| ROIC, 5-yr average | n/a | n/a | n/a |
| ROE, 5-yr average | 25.2%
95th
|
20.7%
82nd
|
10.6%
48th
|
| Incremental ROIC | n/a | n/a | n/a |
Growth
17 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Revenue growth (TTM YoY) | 9.7%
58th
|
-1.1%
14th
|
4.5%
34th
|
| Revenue growth (QoQ) | 7.7%
52nd
|
8.5%
54th
|
4.1%
35th
|
| Revenue CAGR, 3 yr | 12.8%
66th
|
3.7%
23rd
|
6.4%
36th
|
| Revenue CAGR, 5 yr | 11.1%
64th
|
3.3%
16th
|
5.6%
29th
|
| Gross profit CAGR, 3 yr | n/a | n/a | n/a |
| Operating income CAGR, 3 yr | 19.5%
43rd
|
14.0%
29th
|
39.2%
68th
|
| Net income growth (TTM YoY) | -7.7%
9th
|
24.7%
28th
|
53.8%
77th
|
| Net income CAGR, 3 yr | 17.7%
34th
|
3.8%
7th
|
19.7%
38th
|
| EPS growth (TTM YoY) | -7.7%
7th
|
25.5%
28th
|
54.1%
74th
|
| EPS CAGR, 3 yr | 18.0%
31st
|
4.7%
7th
|
19.8%
34th
|
| EPS CAGR, 5 yr | 16.2%
70th
|
-15.5%
6th
|
1.1%
30th
|
| FCF growth (TTM YoY) | n/a | n/a | n/a |
| FCF CAGR, 3 yr | n/a | n/a | n/a |
| Operating cash flow CAGR, 3 yr | n/a | n/a | n/a |
| Book value CAGR, 3 yr | 17.2%
73rd
|
7.4%
22nd
|
8.7%
33rd
|
| Dividend CAGR, 3 yr | 2.6%
42nd
|
-8.1%
3rd
|
0.8%
33rd
|
| Sustainable growth rate | 13.5%
58th
|
8.1%
24th
|
2.6%
7th
|
Margin history & stability
7 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Gross margin, 3-yr average | n/a | n/a | n/a |
| Operating margin, 3-yr average | 17.2%
73rd
|
13.5%
60th
|
10.2%
46th
|
| Net margin, 3-yr average | 14.6%
83rd
|
10.7%
60th
|
8.2%
48th
|
| FCF margin, 3-yr average | n/a | n/a | n/a |
| Revenue stability (0-1) | 0.98
81st
|
0.90
42nd
|
0.99
92nd
|
| Earnings stability (0-1) | 0.85
85th
|
0.48
52nd
|
0.01
4th
|
| Margin stability (0-1) | 0.79
71st
|
0.65
42nd
|
0.81
73rd
|
Liquidity (latest quarter)
7 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Cash & short-term investments | n/a | n/a | n/a |
| Net cash (− = net debt) | n/a | n/a | n/a |
| Working capital | n/a | n/a | n/a |
| Current ratio | n/a | n/a | n/a |
| Quick ratio | n/a | n/a | n/a |
| Cash ratio (cash + ST investments / current liabilities) | n/a | n/a | n/a |
| Defensive interval (days) | n/a | n/a | n/a |
Leverage & solvency (latest quarter)
13 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Total debt | n/a | n/a | n/a |
| Debt / equity | n/a | n/a | n/a |
| Net debt / equity | n/a | n/a | n/a |
| Debt / assets | n/a | n/a | n/a |
| Debt / capital | n/a | n/a | n/a |
| Debt / EBITDA | n/a | n/a | n/a |
| Net debt / EBITDA | n/a | n/a | n/a |
| Interest coverage (EBIT / interest) | n/a | n/a | n/a |
| Cash interest coverage | n/a | n/a | n/a |
| Debt payback (years of OCF) | n/a | n/a | n/a |
| Liabilities / assets | 30.6%
0th
|
85.4%
83rd
|
84.0%
81st
|
| IS credit model rating | AA+ | AA- | AA- |
| Implied credit spread (bps) | 65
2nd
|
100
58th
|
100
58th
|
Efficiency
11 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Asset turnover | n/a | n/a | n/a |
| Fixed asset turnover | n/a | n/a | n/a |
| Inventory turnover | n/a | n/a | n/a |
| Receivables turnover | n/a | n/a | n/a |
| Days sales outstanding | n/a | n/a | n/a |
| Days inventory outstanding | n/a | n/a | n/a |
| Days payables outstanding | n/a | n/a | n/a |
| Cash conversion cycle (days) | n/a | n/a | n/a |
| Capex / revenue | n/a | n/a | n/a |
| Capex / depreciation | n/a | n/a | n/a |
| Operating expense ratio | n/a | n/a | n/a |
Cash flow & earnings quality
7 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Operating cash flow / net income | n/a | n/a | n/a |
| FCF / net income | n/a | n/a | n/a |
| FCF / operating cash flow | n/a | n/a | n/a |
| Capex / operating cash flow | n/a | n/a | n/a |
| Accruals ratio | n/a | n/a | n/a |
| Sloan accruals ratio | n/a | n/a | n/a |
| Earnings quality score (0-1) | n/a | n/a | n/a |
Scores & forensic checks
15 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| IS score | 64
79th
|
53
31st
|
54
35th
|
| IS profitability | 67
81st
|
54
54th
|
36
21st
|
| IS growth | 43
14th
|
57
28th
|
60
46th
|
| IS value | 51
21st
|
72
44th
|
86
75th
|
| IS momentum | 70
24th
|
84
40th
|
88
56th
|
| IS risk (safety) | 100
19th
|
100
19th
|
100
19th
|
| IS quality | 82
85th
|
77
46th
|
76
44th
|
| IS balance sheet | 84
92nd
|
61
21st
|
58
12th
|
| IS earnings quality | 74
85th
|
71
62nd
|
72
77th
|
| IS cash flow | 67
44th
|
66
33rd
|
66
35th
|
| Piotroski F-score (0-9) | 6
33rd
|
6
33rd
|
8
87th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −9.99
0th
|
−5.58
69th
|
−6.47
55th
|
| IS credit score | 90
56th
|
85
35th
|
85
35th
|
Size (TTM)
8 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| Market cap | $11.3B
77th
|
$12.4B
79th
|
$13.0B
81st
|
| Revenue | $4.4B
56th
|
$8.2B
75th
|
$15.0B
87th
|
| EBITDA | $768.6M
60th
|
$1.4B
75th
|
$1.8B
85th
|
| Net income | $577.0M
63rd
|
$953.0M
69th
|
$1.3B
85th
|
| Free cash flow | n/a | n/a | n/a |
| Total assets | $3.6B
40th
|
$33.0B
71st
|
$69.9B
88th
|
| Shareholders' equity | $2.5B
60th
|
$4.8B
69th
|
$11.2B
87th
|
| Employees | 6,667
65th
|
8,500
75th
|
6,600
63rd
|
Price performance
9 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| 1 day | +2.1% | +2.3% | +1.3% |
| 1 week | +9.8% | +6.4% | +3.8% |
| 1 month | +0.4% | +5.1% | −0.6% |
| 3 months | +9.0% | +5.5% | −9.4% |
| 6 months | +0.8% | +14.9% | −0.6% |
| Year to date | −10.2% | +14.9% | +7.6% |
| 1 year | −21.6% | +15.1% | +4.7% |
| 3 years, cumulative | −16.0% | +62.2% | +41.3% |
| 5 years, cumulative | +40.6% | +60.7% | +47.3% |
Technicals
4 measures| Measure | ERIE | AFG | CNA |
|---|---|---|---|
| RSI 14 | 60.9 | 73.7 | 57.1 |
| From 52-week high | −24.5% | −0.1% | −14.0% |
| From 52-week low | +20.6% | +23.4% | +15.4% |
| Beta | 0.33 | 0.58 | 0.27 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17